Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/2012
07/12/2012US20120178805 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
07/12/2012US20120178792 Drg11-responsive (dragon) gene family
07/12/2012US20120178784 Use Of Inhibitors Of The Renin-Angiotensin System
07/12/2012US20120178781 Kappa opioid receptor ligands
07/12/2012US20120178778 Pyrazolopyridines
07/12/2012US20120178774 Toll-like receptor modulators and uses thereof
07/12/2012US20120178759 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
07/12/2012US20120178758 Styryl-triazine derivatives and their therapeutical applications
07/12/2012US20120178743 Novel adenine compound and use thereof
07/12/2012US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/12/2012US20120178737 Tricyclic Heterocyclic Compounds as Phosphoinositide 3-Kinase Inhibitors
07/12/2012US20120178736 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
07/12/2012US20120178735 2h-chromene compound and derivative thereof
07/12/2012US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
07/12/2012US20120178727 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
07/12/2012US20120178726 Novel compounds
07/12/2012US20120178725 Method of modulating ship activity
07/12/2012US20120178723 Heteroaryls and uses thereof
07/12/2012US20120178721 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120178708 Phenethylsulfone isoindoline derivatives and their use
07/12/2012US20120178706 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside
07/12/2012US20120178705 Methods for preparation of glycosphingolipids and uses thereof
07/12/2012US20120178674 Mixture of non-digestible oligosaccharides for stimulating the immune system
07/12/2012US20120178669 Protease inhibitors, compositions and methods of use
07/12/2012US20120178629 Apparatus and methods for preparing an emulsion
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177742 Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore
07/12/2012US20120177740 Drug delivery formulation for controlling of initial burst and manufacturing method thereof
07/12/2012US20120177739 Delayed Release Tablet with Defined Core Geometry
07/12/2012US20120177720 Multi-layer wound dressings
07/12/2012US20120177709 Low ph structured surfactant composition
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177694 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom
07/12/2012US20120177692 Delivery systems for solubilising water-insoluble pharmaceutical active ingredients
07/12/2012US20120177690 Use of rapamycin derivatives in vasculopathies and xenotransplantation
07/12/2012US20120177689 Generation of novel bone forming cells (monoosteophils) from ll-37 treated monocytes
07/12/2012US20120177688 Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology
07/12/2012US20120177687 Gene expressing a bifidobacterium surface-presented fusion protein
07/12/2012US20120177686 Vaccine for the prevention of acute lymphoblastic leukemia
07/12/2012US20120177684 Papillomavirus vaccine compositions
07/12/2012US20120177683 Methods for preparing vesicles and formulations produced therefrom
07/12/2012US20120177682 Helicobacter System and Uses Thereof
07/12/2012US20120177681 Formulation of immunopotentiators
07/12/2012US20120177680 Polypeptides and methods for the specific detection of antibodies in patients with a borrelia infection
07/12/2012US20120177677 Antigen specific multi epitope-based anti-infective vaccines
07/12/2012US20120177676 Alphabodies for hiv entry inhibition
07/12/2012US20120177672 Therapeutic peptides, polypeptides and nucleic acid sequences
07/12/2012US20120177671 Hla-g alpha 1 multimers and pharmaceutical uses thereof
07/12/2012US20120177670 Somatic Stem Cells
07/12/2012US20120177669 Phosphopeptides as melanoma vaccines
07/12/2012US20120177668 Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor
07/12/2012US20120177657 Fusion proteins comprising cd4 minimal modules and methods of use thereof
07/12/2012US20120177655 Anti-human il-21 monoclonal antibodies
07/12/2012US20120177648 Anti-tlr4 antibodies and methods of use thereof
07/12/2012US20120177643 Human cdr-grafted antibody and antibody fragment thereof
07/12/2012US20120177642 Methods of treating inflammatory and autoimmune diseases with natalizumab
07/12/2012US20120177638 Antibodies to vla-1
07/12/2012US20120177636 Carbohydrate-containing pan cancer marker
07/12/2012US20120177600 Compositions and Methods for Inducing or Enhancing Connective Tissue Repair
07/12/2012US20120177598 Compositions and Methods for Immunomodulation in an Organism
07/12/2012US20120177597 Compositions and methods of alteration of autoimmune diseases
07/12/2012US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
07/12/2012US20120177595 Multimeric il-15 soluble fusion molecules and methods of making and using same
07/12/2012US20120177581 Bystander immune suppression as a predictor for response to a vaccine
07/12/2012US20120177568 Novel meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof
07/12/2012US20120177567 Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin
07/12/2012CA2824277A1 Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
07/12/2012CA2823969A1 2,4-diamino-6,7-dihydro-5h-pyrrolo[2,3]pyrimidine derivatives as fak/pyk2 inhibitors
07/12/2012CA2822300A1 Compositions and methods of aloe polysaccharides
07/11/2012EP2474545A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
07/11/2012EP2474534A1 3-Aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
07/11/2012EP2474315A1 Immunity inducer
07/11/2012EP2473508A1 Compounds and compositions as tlr activity modulators
07/11/2012EP2473168A1 Pharmaceutical formulations for indibulin
07/11/2012EP2473049A1 Bruton's tyrosine kinase inhibitors
07/11/2012EP2293785B1 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors
07/11/2012EP2164507B1 Treatment of allergic disease with immunomodulator compounds
07/11/2012EP2034015B1 Immunostimulatory oligonucleotide and pharmaceutical application thereof
07/11/2012EP1979316B1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
07/11/2012EP1767216B1 Drug having regulatory cell ligand contained in liposome
07/11/2012EP1590360B1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
07/11/2012EP1169456B1 Recombinant production of Clostridium difficile Toxin A or Toxin B
07/11/2012CN1688532B Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
07/11/2012CN102575250A Treatment and diagnosis of immune disorders
07/11/2012CN102575231A Process for production of cytokine-induced killer cells
07/11/2012CN102574920A Treatment of autoimmune and inflammatory diseases with epratuzumab
07/11/2012CN102574863A Heterocyclic compounds as JANUS kinase inhibitors
07/11/2012CN102574860A Pyrrolo[2,3-d]pyrimidine compounds
07/11/2012CN102574857A Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/11/2012CN102574844A Maleic acid salt and crystal thereof
07/11/2012CN102574842A Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases
07/11/2012CN102573868A Therapeutic uses for plants of the capsicum genus
07/11/2012CN102573831A Desferrioxamine-metal complexes for the treatment of immune-related disorders
07/11/2012CN102559689A Prawn complement 1q binding protein and application thereof
07/11/2012CN102559636A Antibody fusion protein used for leukemia and autoimmune disease and preparation method thereof
07/11/2012CN102559461A Lotus wine and making process
1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 1172